JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
about
JAK and MPL mutations in myeloid malignancies.The JAK2 exon 12 mutations: a comprehensive review.Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.Genetically heterogeneous origins of idiopathic erythrocytosis.Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.Molecular diagnosis of myeloproliferative neoplasms.Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients.Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis
P2860
Q33378737-3B485B64-0831-47FF-977A-AE4112A7FF34Q34192739-A37BA394-BBFA-4024-9514-A7C589095EEEQ36001930-76217CB7-5157-4051-AF82-804CA7319612Q36799622-DF06FF9D-B6F5-47C1-A74A-AB821EBEE522Q37109225-08DFD8FC-2FD2-4062-9D2E-C3DAFB1F95A0Q37109227-4909B7B5-710C-404C-BAA3-02F9CC24660DQ37310619-FD8C7C5D-4EB0-4266-B26D-5FA0301A2489Q37379320-B8D1ABB7-F95A-4EA9-81E0-0964257A30A8Q37542270-8C00FCE8-78F0-4FEC-8DF7-5214EB2EA263Q40511128-1B9ABFC4-BB79-4D55-A0D4-BE912A2722D8Q44770380-E91FE77E-E94D-46EB-BEEB-AA97ABE506E4Q58010077-2CC00EFE-482E-491B-B769-833E95BC2526
P2860
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
description
im August 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 31 August 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2006
@uk
name
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@en
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@nl
type
label
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@en
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@nl
prefLabel
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@en
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@nl
P2860
P356
P1433
P1476
JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
@en
P2093
P2860
P2888
P356
10.1038/SJ.LEU.2404379
P577
2006-08-31T00:00:00Z